Most Read Articles
Yesterday
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
6 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Elvira Manzano, 12 Nov 2019
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Jairia Dela Cruz, 4 days ago
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.

Taurine supplementation confers benefit for cramps in patients with chronic liver disease

06 Sep 2018

Oral supplementation with taurine is safe and effective in the management of muscle cramps in patients with chronic liver disease, yielding significant reductions in the frequency, duration and intensity of cramps, according to a study.

A total of 49 chronic liver disease patients who had 3 muscle cramp episodes were randomized to receive either taurine supplementation or placebo for 4 weeks then crossed to the alternative arm. Taurine was introduced in a stepped fashion to minimize any potential gastrointestinal side effects: one 500-mg capsule twice daily for 2 weeks and two 500-mg capsules twice daily for the remaining 2 weeks.

Primary outcomes of frequency, duration and intensity of muscle cramps were recorded by the patients themselves. Biochemical parameters, such as serum taurine and methionine levels, were measured at each time point.

Only 30 patients (mean age 54.7 years; 70 percent male) completed the study. Oral taurine resulted in increased serum taurine levels (p<0.001). No adverse side effects associated with supplementation were recorded.

Supplementation dosing of 2 g/day for 2 weeks led to significant reductions in cramp frequency (seven cramp episodes; p=0.03), duration (89 minutes; p=0.03) and severity (1.4 units on a Likert scale; p<0.004) compared with placebo.

The present data suggest that taurine be considered as a safe and effective intervention in the management of muscle cramps in patients with chronic liver disease, researchers said. A daily supplementation dosing of 2 g/day can be safely prescribed to alleviate the painful muscle cramps experienced by patients with cirrhosis.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Yesterday
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
6 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Elvira Manzano, 12 Nov 2019
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Jairia Dela Cruz, 4 days ago
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.